M
Milestone Scientific (MLSS)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX
$0.29
-0.01 (-4.56%)
Market Cap: $27.82M
Last updated: Nov 17, 2026 at 11:05 AM ET
Milestone Scientific (MLSS) Valuation Multiples
Milestone Scientific (MLSS) trades at 3.0x sales and 7.5x book value. Its P/S of 3.0x is below its 5-year median of 6.2x. Its forward P/E is 18.2x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 18.2x |
| Price to sales | 3.0x |
| Price to book | 7.5x |
| PEG | N/A |
| FCF yield | -5.4% |
Historical Medians
Against its 10-year medians, its P/S is 43.4% below 5.3x and its P/B is 3.8% below 7.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 3.0x | 6.2x | 5.3x |
| P/B | 7.5x | 8.6x | 7.8x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 1.3x in 2018 to 23.1x in 2020.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $0.27 | 2.5x | 8.0x |
| 2024 | $0.96 | 8.8x | 12.8x |
| 2023 | $0.69 | 5.1x | 6.5x |
| 2022 | $0.48 | 3.8x | 3.3x |
| 2021 | $2.06 | 13.7x | 8.8x |
| 2020 | $2.12 | 23.1x | 8.6x |
| 2019 | $1.39 | 7.6x | 40.8x |
| 2018 | $0.33 | 1.3x | 8.7x |
| 2017 | $1.18 | 3.5x | 5.7x |
| 2016 | $1.40 | 3.5x | 5.3x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MLSS
What is MLSS's forward P/E ratio?
Milestone Scientific has a forward P/E ratio of 18.2x.
Is MLSS stock overvalued?
GNG's valuation label for MLSS is Undervalued.
What is MLSS's price to sales ratio?
Milestone Scientific has a price to sales ratio of 3.0x.
MLSS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors